SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006132
Filing Date
2024-02-13
Accepted
2024-02-13 16:38:18
Documents
16
Period of Report
2024-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38923
2 ex99-01.htm EX-99.01 21751
3 ex99-01_001.jpg GRAPHIC 2422
  Complete submission text file 0001493152-24-006132.txt   242673

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pali-20240213.xsd EX-101.SCH 3024
5 XBRL LABEL FILE pali-20240213_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pali-20240213_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3662
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 24626754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)